State VA
Clinical Trials in Virginia
Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Virginia
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Georgia
Sponsor
Sanofi
NCT06070870 N/A
Recruiting
Health Education Approach to Lung Screening
Condition
Lung Cancer
Enrollment
675 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT07018323 Phase 2
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatme...
Condition
Graves' Disease
Enrollment
210 pts
Location
United States, Australia, Bulgaria
Sponsor
Immunovant Sciences GmbH
NCT06043440 Phase 2
Recruiting
Down Syndrome Obstructive Sleep Apnea
Condition
Down Syndrome
Enrollment
230 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT06035120 N/A
Recruiting
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Statu...
Condition
Emphysema, Pulmonary
Enrollment
200 pts
Location
United States, Australia, Austria
Sponsor
Pulmonx Corporation
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT06867861 N/A
Recruiting
Effect of Fiber Supplementation on the Need for Medication With Gestational Diab...
Condition
Gestational Diabetes Mellitus (GDM)
Enrollment
110 pts
Location
United States
Sponsor
Eastern Virginia Medical Schoo
NCT06001918 Phase 2, Phase 3
Recruiting
Nectero EAST System Clinical Study
Condition
Abdominal Aortic Aneurysm
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Nectero Medical, Inc.
NCT05784753 N/A
Recruiting
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserv...
Condition
HFpEF - Heart Failure With Preserved Ejection Fraction
Enrollment
300 pts
Location
United States
Sponsor
University of Nebraska
NCT07321886 Phase 3
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight ...
Condition
Obesity
Enrollment
1,980 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT06238622 Phase 3
Recruiting
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With ...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
1,700 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05987241 Phase 2, Phase 3
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the ...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
992 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT04786262 Phase 3
Recruiting
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1...
Condition
Diabetes Mellitus, Type 1
Enrollment
52 pts
Location
United States, Canada, France
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06742723 Phase 3
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the...
Condition
Chronic Kidney Disease and Hypertension
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT04054310 N/A
Recruiting
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Condition
NASH - Nonalcoholic Steatohepatitis
Enrollment
225 pts
Location
United States
Sponsor
Perspectum
NCT05636618 Phase 1, Phase 2
Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2...
Condition
Neuroendocrine Tumors Unresectable
Enrollment
260 pts
Location
United States
Sponsor
Perspective Therapeutics
NCT05905523 N/A
Recruiting
Testing of Online Version of QAPS
Condition
Child Development
Enrollment
1,000 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT05223803 Phase 2
Recruiting
TERPS Trial for de Novo Oligometastic Prostate Cancer
Condition
Prostate Cancer
Enrollment
122 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT00567073 N/A
Recruiting
Pompe Pregnancy Sub-Registry
Condition
Glycogen Storage Disease Type II (GSD-II)
Enrollment
20 pts
Location
United States, Belgium, Croatia
Sponsor
Genzyme, a Sanofi Company
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06297993 N/A
Recruiting
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosi...
Condition
PSC
Enrollment
2,000 pts
Location
United States, Canada, Germany
Sponsor
PSC Partners Seeking a Cure
NCT06369298 Phase 2
Recruiting
Study of JK07 in Patients With Chronic Heart Failure
Condition
Heart Failure With Reduced Ejection Fraction
Enrollment
282 pts
Location
United States, Canada, China
Sponsor
Salubris Biotherapeutics Inc